Dahlquist Karl S.'s Form 4 filing
AtriCure, Inc. (ATRC) · filed Jul 2, 2021
- Accession no.
- 0001209191-21-044872
- Filed
- Jul 2, 2021
- Trade date
- Jun 30-Jul 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $26.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dahlquist Karl S.CIK 0001861996 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2021 | Common Stock | AGrant or awardAcquired | +428 | $45.72F2 | +$19,568.16 | 16,137 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −336 | $79.53 | −$26,722.08 | 15,801 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 4, 2021, which was the first trading day of the applicable offering period. The closing price on January 4, 2021 was $53.79.
Referenced by the price of 1 transaction in Table I.